These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 36240027)

  • 1. Mass Screening of SARS-CoV-2 With Rapid Antigen Tests in a Receding Omicron Wave: Population-Based Survey for Epidemiologic Evaluation.
    Kwan TH; Wong NS; Chan CP; Yeoh EK; Wong SY; Lee SS
    JMIR Public Health Surveill; 2022 Nov; 8(11):e40175. PubMed ID: 36240027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA.1 Periods.
    Marquez C; Kerkhoff AD; Schrom J; Rojas S; Black D; Mitchell A; Wang CY; Pilarowski G; Ribeiro S; Jones D; Payan J; Manganelli S; Rojas S; Lemus J; Jain V; Chamie G; Tulier-Laiwa V; Petersen M; DeRisi J; Havlir DV
    JAMA Netw Open; 2022 Oct; 5(10):e2235844. PubMed ID: 36215069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population Behavior Changes Underlying Phasic Shifts of SARS-CoV-2 Exposure Settings Across 3 Omicron Epidemic Waves in Hong Kong: Prospective Cohort Study.
    Chan CP; Lee SS; Kwan TH; Wong SYS; Yeoh EK; Wong NS
    JMIR Public Health Surveill; 2024 Jun; 10():e51498. PubMed ID: 38896447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
    Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
    JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening Hesitancy of a Universal Voluntary-based Rapid Antigen Test for coronavirus disease 2019 (COVID-19) During Omicron Wave in Hong Kong.
    Wong EL; Qiu H; Wang K; Sun KS; Yam CH; Cheung AW; Yeoh EK
    J Infect Public Health; 2023 Aug; 16(8):1306-1312. PubMed ID: 37336128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of SARS-CoV-2 Infection Among Households With Children in France, 2020-2022.
    Galmiche S; Charmet T; Rakover A; Schaeffer L; Chény O; von Platen C; Omar F; David C; Mailles A; Carrat F; Fontanet A
    JAMA Netw Open; 2023 Sep; 6(9):e2334084. PubMed ID: 37713194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the impact of rapid antigen tests on SARS-CoV-2 transmission in the fifth wave of COVID-19 in Hong Kong in early 2022.
    Du Z; Tian L; Jin DY
    Emerg Microbes Infect; 2022 Dec; 11(1):1394-1401. PubMed ID: 35536564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long COVID in a highly vaccinated but largely unexposed Australian population following the 2022 SARS-CoV-2 Omicron wave: a cross-sectional survey.
    Woldegiorgis M; Cadby G; Ngeh S; Korda RJ; Armstrong PK; Maticevic J; Knight P; Jardine A; Bloomfield LE; Effler PV
    Med J Aust; 2024 Apr; 220(6):323-330. PubMed ID: 38508863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. To PCR or not? The impact of shifting policy from PCR to rapid antigen tests to diagnose COVID-19 during the omicron epidemic: a nationwide surveillance study.
    Chi H; Chiu NC; Chen CC; Weng SL; Lien CH; Lin CH; Hu YF; Lei WT; Tai YL; Lin LY; Liu LY; Lin CY
    Front Public Health; 2023; 11():1148637. PubMed ID: 37546311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multilevel Determinants of COVID-19 Vaccine Uptake Among South Asian Ethnic Minorities in Hong Kong: Cross-sectional Web-Based Survey.
    Singh A; Lai AHY; Wang J; Asim S; Chan PS; Wang Z; Yeoh EK
    JMIR Public Health Surveill; 2021 Nov; 7(11):e31707. PubMed ID: 34653014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Infection, Hospitalization, and Associated Factors Among People Living With HIV in Southeastern China From December 2022 to February 2023: Cross-Sectional Survey.
    Cheng W; Xu Y; Jiang H; Li J; Hou Z; Meng H; Wang W; Chai C; Jiang J
    JMIR Public Health Surveill; 2024 Apr; 10():e51449. PubMed ID: 38630534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hesitancy to Undergo SARS-CoV-2 Rapid Antigen Testing in China: Nationwide Cross-sectional Study.
    Lu Z; Fu L; Yang L; Tian T; Gao Y; Meng X; Zou H
    JMIR Public Health Surveill; 2023 May; 9():e43555. PubMed ID: 36888911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal Household Assessment of Respiratory Illness in Children and Parents During the COVID-19 Pandemic.
    de Hoog MLA; Sluiter-Post JGC; Westerhof I; Fourie E; Heuvelman VD; Boom TT; Euser SM; Badoux P; Reusken C; Bont LJ; Sanders EAM; Jaddoe VWV; Herpers BL; Eggink D; Wildenbeest JG; Duijts L; van Houten MA; Bruijning-Verhagen PCJL
    JAMA Netw Open; 2022 Oct; 5(10):e2237522. PubMed ID: 36264578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics of SARS-CoV-2 Omicron infection in children imported from Hong Kong].
    Ma WJ; Wang XS; Tian H; Zhu YF; Wei ZQ; Xu J; Zhu QR; Zeng M
    Zhonghua Er Ke Za Zhi; 2022 Jun; 60(6):539-544. PubMed ID: 35658359
    [No Abstract]   [Full Text] [Related]  

  • 16. Accuracy of 2 Rapid Antigen Tests During 3 Phases of SARS-CoV-2 Variants.
    Drain PK; Bemer M; Morton JF; Dalmat R; Abdille H; Thomas KK; Uppal TK; Hau D; Green HR; Gates-Hollingsworth MA; AuCoin DP; Verma SC
    JAMA Netw Open; 2022 Aug; 5(8):e2228143. PubMed ID: 36001317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance-based informative testing for detection and containment of SARS-CoV-2 outbreaks on a public university campus: an observational and modelling study.
    Rennert L; McMahan C; Kalbaugh CA; Yang Y; Lumsden B; Dean D; Pekarek L; Colenda CC
    Lancet Child Adolesc Health; 2021 Jun; 5(6):428-436. PubMed ID: 33751952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine-hesitant individuals accumulate additional COVID-19 risk due to divergent perception and behaviors related to SARS-CoV-2 testing: a population-based, cross-sectional study.
    Wratil PR; Kotter K; Bischof ML; Hollerbach S; Apak E; Kalteis AL; Nayeli-Pflantz T; Kaderali L; Adorjan K; Keppler OT
    Infection; 2023 Aug; 51(4):909-919. PubMed ID: 36355269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Importance of Incorporating At-Home Testing Into SARS-CoV-2 Point Prevalence Estimates: Findings From a US National Cohort, February 2022.
    Qasmieh SA; Robertson MM; Rane MS; Shen Y; Zimba R; Picchio CA; Parcesepe AM; Chang M; Kulkarni SG; Grov C; Nash D
    JMIR Public Health Surveill; 2022 Dec; 8(12):e38196. PubMed ID: 36240020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.